Delivery Order SPE2DB24D2010-SPE2DB25FABDC
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Januvia 50 mg tablets (90-count packages) valued at $2,678.60. This is a firm fixed-price delivery order with a completion date of July 25, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,196.24 by the Defense Logistics Agency on August 21, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement with an ultimate completion date of August 22, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,091.46 for 90 tablets of Januvia 50 mg. The contract, which was not set-aside, is scheduled for completion by August 1, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $1,721.17 for 90 tablets of Januvia 100 mg. The contract was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, under a firm fixed price arrangement with no set-aside designation. The product will be delivered to the Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for Januvia 100 mg tablets (90-count units) on July 28, 2025, with a ceiling value of $2,218.86. This is a firm fixed price, non-set-aside contract with a completion date of July 29, 2025. The award was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,025.75 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This delivery order operates...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a ceiling value of $10,411.20 and an ultimate completion date of August 5, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $40,455.90 by the Defense Logistics Agency (DLA) for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $1,942.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for 90 tablets of Januvia 100 mg, a diabetes management medication. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABDCDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $59,928.45 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of 1,000 tablets of Januvia 100 mg. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 10, 2025, and will be performed at the contractor's Conshohocken facility. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The DLA's procurement of Januvia, a diabetes management medication, supports the military healthcare supply chain's requirement for essential pharmaceutical products to serve Defense Health Agency beneficiaries, including active-duty personnel, retirees, and their families. AmerisourceBergen's substantial IDC with the DLA enables the company to supply a wide range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This particular delivery order exemplifies the routine pharmaceutical procurement activities conducted under this prime vendor arrangement, which consolidates federal purchasing efficiency while maintaining competition through the DLA's planned multi-award strategy for future pharmaceutical prime vendor contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.9k | 9/9/25 |